about
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytesAutologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegenerationCannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammationPalmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptideCannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementCannabidiol reduces intestinal inflammation through the control of neuroimmune axisThe marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cellsCannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitroNovel bioactive sulfated alkene and alkanes from the mediterranean ascidian Halocynthia papillosa.Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-αAdelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.Cannabidiol: a promising drug for neurodegenerative disorders?S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells.OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expressionSelective CB2 up-regulation in women affected by endometrial inflammation.Cannabidiol in inflammatory bowel diseases: a brief overview.Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement.CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.Induction of nitric oxide synthase expression by Withania somnifera in macrophages.Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells.S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease.S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in micePalmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells.Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein.Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress.The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation.Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells.Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection.Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms
P50
Q26797413-DF86B868-2179-4D33-8054-B5F77B4B2CBCQ27334336-862CBD77-77E7-4017-8D0F-60AC9F46A8C2Q28361058-2475F12D-6AA5-4211-A056-7B4C63917046Q28390536-6DA4450B-FF55-483E-A446-D0DFAFC4AD20Q28394506-1FEA4CB5-6827-483C-97C2-DB803EA20A51Q28478272-E475C848-F4CE-4791-8533-01178A46680FQ28575370-561A978F-0B84-4743-AAF5-133D3BAF3401Q29144178-C4601190-5FA3-41C0-BD62-24C330D2AEE6Q31591587-AFD5D87C-782C-499A-B590-90D4E2536CFDQ34636570-FB82E457-24E2-40C4-AAC5-31E2F8A31B24Q34772868-2AECD913-5C00-4C19-B396-8591BFF9CEE9Q34849183-B2EECF6F-9F6C-44E3-874F-5049FB5A28C9Q34948216-35D7D6AC-E1EC-4F54-8B6C-2259F5B95DE4Q35681474-4AF92514-23E5-4DFA-87CC-2774820A0625Q35909445-A11D7F02-6D64-48FD-967B-417FD9576FA4Q36358055-AE86BF13-0BE3-40BC-ABD0-3130157FEB9FQ37293889-C55B6D50-5AB9-46E1-B7A7-CF1D162EBCEDQ38027809-1A5BE13E-8FAC-44BD-8A21-DBDD5DF04940Q38296660-67365304-7156-46C3-B2F7-3A9319BC6EB1Q38895988-EE846A64-CC40-497C-A235-87D475C135F4Q39052200-D8910075-3C84-4E8A-A5F9-D5DEE39EEE7CQ40256386-0D73C1DA-E383-49E0-8534-8AA87BD48A43Q40313822-7A948DBC-ACB5-4AFF-9136-EFEFF3967AA7Q40674828-2AF08319-D08D-497B-9CD1-84A09CC5B77EQ40783943-14278133-4600-451B-8344-63F307D1A262Q41819939-07D64C5F-5D66-414B-981F-09C9F7FCC1C1Q41863070-412CD2AB-8B85-4052-B349-B859235F0D65Q42117982-70A4D529-77CA-4696-89E8-247743E05DE3Q43617967-CBE54BDF-CB91-49EA-B816-EED084A6252EQ44804966-14FF90AD-EF7B-49A5-A5FA-8357F069F4BAQ45951035-31DA1282-C6EB-4A20-AB60-7F3CA905AC07Q46676453-0293C58D-050D-4DCD-A3B5-6BBA9871E1A7Q46851688-F6C68545-E478-4FBC-8999-ABD85CDAA976Q46867456-527C5391-1527-41FE-9F37-41A51A9E05B6Q47143965-3290444E-319D-4E51-8A25-9ECDC16E7893Q48148192-B3366B4F-9067-47E6-AFC1-001A300DC92EQ48260636-C7BACBC0-4798-448C-BC71-36750D558B50Q48518739-75284FB3-2034-465A-8690-73D34BC0E09CQ51734371-49BD4DF1-16EE-49B3-9ED5-0B3E2D82743FQ57157884-89D8F195-722A-47EC-A221-27881754C50B
P50
description
researcher ORCID: 0000-0001-8080-8218
@en
name
Giuseppe Esposito
@ast
Giuseppe Esposito
@en
Giuseppe Esposito
@es
Giuseppe Esposito
@nl
Giuseppe Esposito
@sl
type
label
Giuseppe Esposito
@ast
Giuseppe Esposito
@en
Giuseppe Esposito
@es
Giuseppe Esposito
@nl
Giuseppe Esposito
@sl
prefLabel
Giuseppe Esposito
@ast
Giuseppe Esposito
@en
Giuseppe Esposito
@es
Giuseppe Esposito
@nl
Giuseppe Esposito
@sl
P106
P21
P2798
P31
P496
0000-0001-8080-8218